The feasibility of HIV vaccine efficacy trials among Russian injection drug users
- PMID: 17707960
- PMCID: PMC3747029
- DOI: 10.1016/j.vaccine.2007.07.028
The feasibility of HIV vaccine efficacy trials among Russian injection drug users
Abstract
IDU exposure remains a primary driver of the Russian HIV epidemic, and recent incidence data provide little evidence that this epidemic is slowing. While there are multiple important challenges that need to be further explored before starting vaccine trials, most importantly access to evidence-based drug treatment services for trial participants, the current context of high HIV incidence and low genetic diversity of HIV strains, suggests the need for intensified prevention strategies and supports the feasibility of mounting efficacy trials of HIV vaccines among IDUs in the Russian Federation.
References
-
- Aceijas C, Stimson GV, Hickman M, Rhodes T. United Nations Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries. Global overview of injecting drug use and HIV infection among injecting drug users. AIDS. 2004;18(17):2295–303. - PubMed
-
- Field MG. HIV and AIDS in the Former Soviet Bloc. N Engl J Med. 2004;351(2):117–20. - PubMed
-
- Dehne KL, Khodakevich L, Hamers FF, Schwartlander B. The HIV/AIDS epidemic in eastern Europe: recent patterns and trends and their implications for policy-making. AIDS. 1999 May 7;13(7):741–9. - PubMed
-
- Rhodes T, Platt L, Maximova S, et al. Prevalence of HIV, hepatitis C and syphilis among injecting drug users in Russia: a multi-city study. Addiction. 2006 Feb;101(2):252–66. - PubMed
-
- McMichael AJ. HIV vaccines. Annu Rev Immunol. 2006;24:227–55. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical